The suzetrigine, which only acts on pain neurons, is the first innovation in analgesia in the last 20 years. "It stands out ...

Notice how an Old Fashioned has one large ice cube, while tropical drinks are poured over crushed ice? There's a scientific ...

For the first time in decades, a new class of painkiller has been approved by the US Food and Drug Administration (FDA).

Vertex Pharmaceuticals forecast annual revenue largely above Wall Street estimates on Monday, banking on robust sales of its ...

Utilizing the company's electronic bookkeeping system, Haptonstall would assign the same number to a fraudulent check payable to herself and a legitimate check payable to one of the company's vendors, ...

The Dateline NBC episode titled, 'The Window' features the case of the mysterious fall of Hannah Hove from 75 feet.

Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

The FDA has approved Journavx, a new non-opioid painkiller designed to treat moderate to severe acute pain. Unlike opioids, ...

For the first time in 20 years, the Food and Drug Administration has approved a new pharmaceutical approach to treating pain. On January 31, the FDA approved Journavx as ...

By Rick Winterson  Vertex Pharmaceuticals is a worldwide biotechnology corporation. It was founded 35 years ago in Cambridge.  It has now established its global headquarters on Fan Pier in South ...

A new non-opioid painkiller, suzetrigine, has just been approved by the US drug regulator, the FDA. It is the first ...

Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.